eyestock logo

eyestock

SA

Sakar Healthcare LtdNSE SAKAR

Последний отчетный период 30 сент., 2023

Обновлено 11 нояб., 2024

Последняя цена

Капитализация млрд. $

0.033

Micro

Биржа

XNSE - National Stock Exchange Of India

Анализ акций SAKAR.NS

SA

Нет оценки

Количественный анализ Eyestock не покрывает акции Sakar Healthcare Ltd.

Капитализация млрд. $

0.033

Дивидендная доходность

Оборот

21.75 млрд

Сайт компании

http://www.sakarhealthcare.com/

Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat and currently employs 297 full-time employees. The company went IPO on 2016-10-14. The firm is engaged in providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules, vials and lyophilized injections, oral solid dosages, and research and development of these products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin - Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract development and manufacturing organization (CDMO). The firm has approximately 321 product registrations in various countries. The manufacturing unit has been accredited by regulatory authorities of 14 countries, which includes Uganda, Kenya, Yemen, Ethiopia, Congo, Zimbabwe, Nigeria, Malawi, Philippines, Peru, Vietnam, Cote D’Ivoire.

Смотреть Секцию: Рейтинг